AJANTPHARM.BO
Ajanta Pharma Limited$2,977.60
Jun 05, 2026
Market cap
$371.87B
52w range
—
P / E
—
EPS · FY 2026
$84.53
Volume
—
Revenue · FY 2026
$54.53B
Explain this page
Arphra AIPlain-English read on Ajanta Pharma Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,894.67
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Real Estate+1.72%
- Consumer Defensive+1.53%
- Consumer Cyclical+1.11%
- Financial Services+0.93%
- Communication Services-0.36%
- Healthcare-0.60%
- Energy-1.07%
- Basic Materials-1.68%
- Industrials-1.83%
- Utilities-1.92%
- Technology-4.41%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic+0.85%
- Solar-8.07%
- Computer Hardware-6.99%
- Investment - Banking & Investment Services-5.17%
- Hardware, Equipment & Parts-5.09%
- Silver-5.08%
- Furnishings, Fixtures & Appliances+4.46%
- Software - Infrastructure-3.90%
- Engineering & Construction-3.68%
- Communication Equipment-3.56%
- Gold-3.53%
- Oil & Gas Drilling-3.48%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for AJANTPHARM.BO.
Peers
No peer list available for AJANTPHARM.BO.
Total assets
$61.55B
Total debt
$2.6B
Cash & equiv
$1.05B
Operating CF
$5.16B
Free cash flow
$1.51B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $54.53B | $13.25B | $10.56B | $84.53 | +19.37% |